OCI.AS OCI N.V. EURONEXT Intraday 16 Mar 2026: earnings ahead, watch cash outlook

The market is watching OCI N.V. (OCI.AS) ahead of its earnings due 16 Mar 2026, and the OCI.AS stock trades at €3.54 intraday after a -4.84% move on the session so far. Volume is elevated at 556,822 shares versus an average of 921,750, reflecting short-term positioning into the report. Investors will focus on cash generation, project updates including Beaumont New Ammonia, and any guidance revisions that could drive a volatile reaction after the close.

OCI.AS stock: intraday price, volume and earnings timing

OCI N.V. (OCI.AS) is trading on EURONEXT in Europe at €3.54 with a day range of €3.52–€3.73. The company’s earnings release is scheduled for 16 Mar 2026 at 16:30 UTC, creating an intraday catalyst for liquidity and swings. Market participants note the 50-day average price of €3.45 and the 200-day average of €4.66, which frame short-term support and medium-term resistance levels.

OCI.AS stock earnings drivers: projects, volumes and margin signals

Primary earnings drivers are fertilizer and methanol margins and throughput across the Methanol and Nitrogen segments, and any updates on the Beaumont New Ammonia project and potential Orascom Construction merger could change medium-term EBITDA expectations. Recent coverage notes Beaumont is on track for late-2025 completion and is expected to support export volumes and EBITDA expansion Investing.com source. We expect the market to parse commentary on utilisation, feedstock costs and contract mix as direct drivers of EPS and operating cash flow.

OCI.AS stock financials and valuation metrics

Key ratios show mixed fundamentals: reported EPS is -€1.34 and reported PE is -2.80, while book value per share is €8.53 and cash per share is €8.08, signalling a strong balance sheet cushion relative to the market price. Market cap stands at €791,022,488 with 210,939,330 shares outstanding. Price-to-book is 0.50 and price-to-sales is 1.69, implying the market prices future cyclical risk into the stock. Interest coverage and operating cash flow remain watchpoints given recent negative operating cash flow per share of -€1.86.

Meyka AI rates OCI.AS with a score out of 100 and technicals

Meyka AI rates OCI.AS with a score out of 100: 68.17/100 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. On technicals the RSI is 60.59, MACD is 0.06, and the stock sits above its 50-day average but below the 200-day average, a mixed signal for traders. Short-term momentum indicators (CCI 218.60) show overbought readings intraday, increasing the chance of a profit-taking reaction on any disappointing numbers.

OCI.AS stock trading view and price targets

Trading setup: intraday support near €3.45 (50-day MA) and immediate resistance near €3.76 (upper Bollinger Band). Meyka AI recommends watching block volume and the post-earnings release for directional conviction. Price targets: conservative €2.80, base €5.00, bull €7.50, anchored to balance sheet values and potential EBITDA recovery. These targets reflect the stock’s year high of €11.35 and year low of €2.55, and assume varying scenarios for commodity margins and project execution.

News, catalysts and sector context for OCI.AS stock

Sector context: OCI operates in Basic Materials, Chemicals – Specialty, where peers have mixed YTD performance; investors watch commodity price swings and industrial demand cycles. Recent coverage flagged Beaumont and a potential tie-up with Orascom as strategic catalysts that could materially alter cash flow profiles Investing.com source. Short-term catalysts include the earnings release, any revised guidance, and announcements on project financing or partnerships.

Final Thoughts

OCI.AS stock enters today’s earnings with €3.54 per share and elevated intraday volume, making it vulnerable to a sharp move when management reports results and guidance. Meyka AI’s forecast model projects a quarterly target of €6.76, implying an upside of 90.96% versus the current price, while a monthly projection of €2.43 implies a downside of -31.36%; forecasts are model-based projections and not guarantees. Our view: treat the report as a catalyst, not a thesis change—positive free cash flow guidance or faster-than-expected Beaumont ramp-up supports the base and bull targets, while weak operating cash flow or larger-than-expected receivables pressures risk the conservative case. Use intraday risk controls; expect volatility given RSI and CCI readings and reliance on project execution and commodity margins. For real-time alerts and model updates, refer to Meyka AI’s AI-powered market analysis tools and the company disclosures after the close.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.